☰

Mythili Koneru, Ph.D. - Publications

Affiliations: 
2004 New York University, New York, NY, United States 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Yeku OO, Purdon TJ, Koneru M, Spriggs D, Brentjens RJ. Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment. Scientific Reports. 7: 10541. PMID 28874817 DOI: 10.1038/s41598-017-10940-8  0.48
2016 Rafiq S, Purdon TJ, Daniyan AF, Koneru M, Dao T, Liu C, Scheinberg DA, Brentjens RJ. Optimized T-cell receptor-mimic (TCRm) chimeric antigen receptor T-cells directed towards the intracellular Wilms Tumor 1 antigen. Leukemia. PMID 27924074 DOI: 10.1038/Leu.2016.373  0.524
2015 Koneru M, Purdon TJ, Spriggs D, Koneru S, Brentjens RJ. IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo. Oncoimmunology. 4: e994446. PMID 25949921 DOI: 10.4161/2162402X.2014.994446  0.415
2015 Chang PS, Lee JC, Koneru M, Brentjens RJ. 408. CD19-Targeted CAR T Cells “Armored” To Secrete IL-12 Demonstrate Superior Efficacy Against B Cell Acute Lymphoblastic Leukemia and Resist Treg Immunosuppression Molecular Therapy. 23: S161. DOI: 10.1016/S1525-0016(16)34017-5  0.392
2008 Lin SY, Yang J, Everett AD, Clevenger CV, Koneru M, Mishra PJ, Kamen B, Banerjee D, Glod J. The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Experimental Cell Research. 314: 3107-17. PMID 18722367 DOI: 10.1016/J.Yexcr.2008.07.028  0.413
2007 Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells (Dayton, Ohio). 25: 520-8. PMID 17053212 DOI: 10.1634/stemcells.2006-0257  0.404
2006 Koneru M, Monu N, Schaer D, Barletta J, Frey AB. Defective adhesion in tumor infiltrating CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 176: 6103-11. PMID 16670319 DOI: 10.4049/Jimmunol.176.10.6103  0.623
2005 Koneru M, Schaer D, Monu N, Ayala A, Frey AB. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function. Journal of Immunology (Baltimore, Md. : 1950). 174: 1830-40. PMID 15699109 DOI: 10.4049/Jimmunol.174.4.1830  0.638
2005 Simmons WJ, Koneru M, Mohindru M, Thomas R, Cutro S, Singh P, Dekruyff RH, Inghirami G, Coyle AJ, Kim BS, Ponzio NM. Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms. Journal of Immunology (Baltimore, Md. : 1950). 174: 1405-15. PMID 15661898 DOI: 10.4049/Jimmunol.174.3.1405  0.577
2001 Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, Frey AB. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. Journal of Immunology (Baltimore, Md. : 1950). 167: 5042-51. PMID 11673513 DOI: 10.4049/Jimmunol.167.9.5042  0.624
Show low-probability matches.